ANI Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Minnesota, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
210 W Main St, Baudette, Minnesota, 5662...Phone Number
(218) 634-3500Website
www.anipharmaceuticals.comRevenue
$923.7 MillionStock Symbol
ANIPIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
6
7
1
2
1
2
About ANI Pharmaceuticals
ANI Pharmaceuticals, Inc. is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products. Our team is focused on delivering sustainable growth by building a successful Purified Cortrophin Gel franchise, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities.Explore more
ANI Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ANI Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on ANI Pharmaceuticals recently announced quarterly report
Click to see if ANI Pharmaceuticals had a recent Job posting/layoffs
Funding: Get notified immidiatlly once ANI Pharmaceuticals has new funding data
Congratulate Masked Content for being promoted to Masked Content at ANI Pharmaceuticals
Check if ANI Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
ANI Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if ANI Pharmaceuticals is spiking on competitors!
Product Launch: Get notified when ANI Pharmaceuticals launches new products
Recommended Actions
Find VP level buyers at ANI Pharmaceuticals
Find 3 more new buyers
Compare Similar Companies to ANI Pharmaceuticals
Compare insights from companies similar to ANI Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ANI Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ANI Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ANI Pharmaceuticals.
ANI Pharmaceuticals financials insights
Gather financial insights about ANI Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Share Placement
$125M
2024
Debt
$280M
ANI Pharmaceuticals Tech Stack
A closer look at the technologies used by ANI Pharmaceuticals
See more technologies
Most Recent Scoops
Hiring Plans
ANI Pharmaceuticals has more open roles in Operations than it has had at any time in the past 6 months.
Hiring Plans
Person-Based
Award
Person-Based
Person-Based
Person-Based
Pharmaceuticals
ANI Pharmaceuticals News & Media
Q1 Earnings Outperformers: ANI Pharmaceuticals (NASDAQ:ANIP) And The Rest Of The Pharmaceuticals Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ANI Pharmaceuticals (NASDAQ:ANIP) and the best and worst performers in the pharmaceuticals industry.ANI Pharmaceuticals, Inc. (ANIP): A Small Cap Value Stock Capitalizing on Generic Drugs Opportunities
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) is one of the best small-cap value stocks to buy. On April 20, ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) confirmed the Food and Drug Administration’s approval of Pimozide Tablets in 1 mg and 2 mg strengths. Following approval, the company has launched Pimozide tablets, a generic version of the reference listed drug (RLD) […]ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance
PRINCETON, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced financial results and business highlights for the first quarter ended March 31, 2026.Pentoxifylline Drug Market Is Going to Boom Rapidly | Sanofi India Ltd, ANI Pharmaceuticals Inc, Cipla Ltd
The Global Pentoxifylline Drug Market is estimated to be valued at USD 515.2 Mn in 2026 and is expected to reach USD 821.8 Mn by 2033. BURLINGAME, CA, UNITED STATES, May 7, 2026 /EINPresswire.com/ -- The Global Pentoxifylline Drug Market is estimated to …
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ANI Pharmaceuticals
Sign Up For FreeTo access detailed company insights
ANI Pharmaceuticals, Inc. is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products. Our team is focused on delivering sustainable growth by building a successful Purified Cortrophin Gel franchise, strengthening our generics... Read More
